Yildiz O, Tuncer M
Department of Pharmacology, Faculty of Medicine, Gülhane Military Medical Academy, Ankara, Turkey.
Naunyn Schmiedebergs Arch Pharmacol. 1995 Aug;352(2):127-31. doi: 10.1007/BF00176765.
The contractions induced by 5-hydroxytryptamine (5-HT) and the 5-HT1-like receptor agonist, sumatriptan, were investigated in the open ring preparations of rabbit mesenteric artery in order to characterize the 5-HT receptors. 5-HT induced concentration-dependent contractions. Sumatriptan did not induce any contraction of unstimulated rings, whereas it elicited concentration-dependent contractions in preparations given a moderate tone by a threshold concentration of prostaglandin F2 alpha (PGF2 alpha). Pargyline, cocaine or normetanephrine were without significant effect on the contractions induced by 5-HT and sumatripan. The 5-HT concentration-effect curve was clearly biphasic. Methiothepin (0.01 microM) shifted the both phases of the concentration-effect curve to the right. Ketanserin (0.1 microM) shifted the second, low affinity, phase and prazosin did not alter concentration-effect curve to 5-HT. The sumatriptan concentration-effect curve was shifted by methiothepin (0.01 microM) to the right (pKB = 9.19) but not by ketanserin (1 microM). Concentration-effect curves to 5-HT and sumatriptan were not affected by the 5-HT3 receptor antagonist tropisetron (1 microM). These results suggest that 5-HT1-like type receptors are responsible for the first phase of 5-HT-induced contraction and 5-HT2A receptor for the second phase, in rabbit mesenteric artery. Sumatriptan-induced contractions appear to be mediated by 5-HT1-like type receptors in this artery. These results also suggest that this kind of amplification may be a common feature of vascular 5-HT1-like type receptor as has been shown in other vascular segments such as rabbit femoral, iliac and renal arteries, and guinea-pig iliac artery.
为了对5-羟色胺(5-HT)受体进行特性描述,研究了5-羟色胺(5-HT)和5-HT1样受体激动剂舒马曲坦在兔肠系膜动脉开放环制备物中所诱导的收缩。5-羟色胺(5-HT)诱导浓度依赖性收缩。舒马曲坦未诱导未刺激环的任何收缩,而在给予阈值浓度的前列腺素F2α(PGF2α)以产生适度张力的制备物中,它引发浓度依赖性收缩。帕吉林、可卡因或去甲变肾上腺素对5-羟色胺(5-HT)和舒马曲坦所诱导的收缩无显著影响。5-羟色胺(5-HT)浓度-效应曲线明显呈双相性。甲硫哒嗪(0.01微摩尔)使浓度-效应曲线的两个阶段均右移。酮色林(0.1微摩尔)使第二个低亲和力阶段右移,而哌唑嗪未改变5-羟色胺(5-HT)的浓度-效应曲线。舒马曲坦浓度-效应曲线被甲硫哒嗪(0.01微摩尔)右移(pKB = 9.19),但未被酮色林(1微摩尔)右移。5-羟色胺(5-HT)和舒马曲坦的浓度-效应曲线不受5-HT3受体拮抗剂托烷司琼(1微摩尔)的影响。这些结果表明,在兔肠系膜动脉中,5-HT1样型受体负责5-羟色胺(5-HT)诱导收缩的第一阶段,而5-HT2A受体负责第二阶段。舒马曲坦诱导的收缩似乎在此动脉中由5-HT1样型受体介导。这些结果还表明,这种放大作用可能是血管5-HT1样型受体的一个共同特征,正如在其他血管段如兔股动脉、髂动脉和肾动脉以及豚鼠髂动脉中所显示的那样。